Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases (Q36117824)

12 August 2017

1 reference

title

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases (English)

1 reference

12 August 2017

cardiovascular disease

1 reference

Hana Rosolova

1

1 reference

PMCID

3405365

12 August 2017

Barbora Nussbaumerova

series ordinal

2

1 reference

12 August 2017

5 March 2011

1 reference

12 August 2017

1 reference

12 August 2017

2

1 reference

12 August 2017

15-26

1 reference

12 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s13167-011-0066-1

12 August 2017

0 references

cites work

Coronary artery calcium progression: an important clinical measurement? A review of published reports

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Association of a fasting glucose genetic risk score with subclinical atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Effects of combination lipid therapy in type 2 diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Effects of intensive glucose lowering in type 2 diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice ...

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Kidney-heart interactions: epidemiology, pathogenesis, and treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Impact of high-normal blood pressure on the risk of cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Hyperglycemia and cardiovascular disease in type 2 diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Banting lecture 1988. Role of insulin resistance in human disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

2 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Age and gender are the strongest clinical correlates of prevalent coronary calcification (R1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Relationship and prognostic value of coronary artery calcification by electron beam computed tomography to stress-induced ischemia by single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

The relationship between the 'metabolic score' and sub-clinical atherosclerosis detected with electron beam computed tomography

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Triglycerides and the Risk of Coronary Heart Disease

23 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Coronary Artery Calcification and Its Relationship to Validated Genetic Variants for Diabetes Mellitus Assessed in the Heinz Nixdorf Recall Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13167-011-0066-1

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3405365

Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23199124

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The presence, characterization and prognosis of coronary plaques among patients with zero coronary calcium scores

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23199124

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23199124

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13167-011-0066-1

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

3405365